IN RECENT reports1 we stated that our experience with the use of corticotropin (ACTH) in the early progressive stages of retrolental fibroplasia gave us some hope that it might prove effective. This hope has not been realized. The present paper covers infants born between Dec. 15, 1949, and July 25, 1951. The treatment of infants born during this time was begun between February, 1950, and August, 1951, a 19-month experience.
Source of Material Studied.
—Cases of retrolental fibroplasia considered in this report occurred in two New York hospitals—Babies Hospital and Lincoln Hospital.
Selection of Cases for Treatment.
—In selecting the cases for treatment, it was important to make the decision before irreversible fundus changes occurred and, at the same time, not to choose cases in which there was a reasonable chance of spontaneous regression. The only chance of salvaging a useful eye was to arrest the disease before
REESE AB, BLODI FC, LOCKE JC, SILVERMAN WA, DAY RL. RESULTS OF USE OF CORTICOTROPIN (ACTH) IN TREATMENT OF RETROLENTAL FIBROPLASIA. AMA Arch Ophthalmol. 1952;47(5):551–555. doi:10.1001/archopht.1952.01700030565001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: